Drug search by name

Mycophenolic Acid Delayed-Release Tablets and PML

Result of checking the interaction of drug Mycophenolic Acid Delayed-Release Tablets and disease PML for safety when used together.

Check result:

Mycophenolic Acid Delayed-Release Tablets <> PML

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Immunosuppressive agents may increase the risk of progressive multifocal leukoencephalopathy (PML). Certain agents are contraindicated in patients who have or have had PML. Patients receiving chronic immunosuppressant or immunomodulatory therapy or who have systemic medical conditions resulting in significantly compromised immune system function should not be treated with these agents. Healthcare professionals should monitor patients for any new sign or symptom suggestive of PML. Withhold therapy dosing immediately and perform an appropriate diagnostic evaluation at the first sign or symptom suggestive of PML.

Mycophenolic Acid Delayed-Release Tablets

Generic Name: mycophenolic acid

Brand Name: Myfortic

Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release

What is Mycophenolic Acid Delayed-Release Tablets?